Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19

AIMS: Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on prognosis in patients with type 2 diabetes hospitalised for COVID-19. METHODS: CORONADO is a nationwide observational study that included patients with diabetes hospitalised for...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Diabetes Metab
Päätekijät: Lalau, Jean-Daniel, Al-Salameh, Abdallah, Hadjadj, Samy, Goronflot, Thomas, Wiernsperger, Nicolas, Pichelin, Matthieu, Allix, Ingrid, Amadou, Coralie, Bourron, Olivier, Duriez, Thierry, Gautier, Jean-François, Dutour, Anne, Gonfroy, Céline, Gouet, Didier, Joubert, Michael, Julier, Ingrid, Larger, Etienne, Marchand, Lucien, Marre, Michel, Meyer, Laurent, Olivier, Frédérique, Prevost, Gaëtan, Quiniou, Pascale, Raffaitin-Cardin, Christelle, Roussel, Ronan, Saulnier, Pierre-Jean, Seret-Begue, Dominique, Thivolet, Charles, Vatier, Camille, Desailloud, Rachel, Wargny, Matthieu, Gourdy, Pierre, Cariou, Bertrand
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier Masson SAS. 2021
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7832745/
https://ncbi.nlm.nih.gov/pubmed/33309936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diabet.2020.101216
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia